Company Filing History:
Years Active: 2008-2010
Title: Ingo Tamm: Innovator in Apoptosis Modulation
Introduction
Ingo Tamm is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of cellular apoptosis, particularly through his research on the hepatitis B X-interacting protein (HBXIP). With a total of 2 patents, Tamm's work has the potential to impact cancer treatment and cellular regulation.
Latest Patents
Tamm's latest patents focus on novel methods of regulating cellular apoptosis by affecting the interaction of HBXIP with Survivin. These innovative methods aim to enhance the apoptosis of neoplastic cells by inhibiting the interaction between HBXIP and Survivin using siRNA or antisense compounds. This research could lead to new therapeutic strategies for cancer treatment.
Career Highlights
Throughout his career, Ingo Tamm has worked at prestigious institutions, including the Burnham Institute for Medical Research and The Burnham Institute. His research has been pivotal in understanding the mechanisms of apoptosis and its implications in cancer biology.
Collaborations
Tamm has collaborated with notable figures in the field, including John C. Reed. These partnerships have furthered the research and development of innovative approaches to cancer treatment.
Conclusion
Ingo Tamm's contributions to the field of apoptosis modulation highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer therapies and cellular regulation.